a little about...
The Cancer Research Trust
Mission
To enable cancer research in Western Australia (WA) that is unique, excellent, and collaborative.
Vision
The Cancer Research Trust’s (CRT) vision is to make an internationally significant contribution to the diagnosis, prevention, and treatment of cancer. To achieve this, we are actively driving world-class innovative and collaborative research in WA, and reversing the brain drain by enticing back to Perth our most valuable export, world leaders in medical research.
Research
The CRT WA Collaborative Cancer Research Grant was created and first awarded in 2017 via a competitive application process to support a leading-edge cancer research capability in WA, with a focus on sustainability, longevity, and continuity.
The CRT is currently funding two major world class collaborative cancer research projects awarded WA Collaborative Research Grants in 2017 and 2020, respectively:
- In 2017, funding of up to $6.75m plus an additional 30% matched funding for up to nine years was awarded to Chief Investigator Professor Alistair Forrest’s (Harry Perkins Institute for Medical Research) grant application “Enabling Advanced Single Cell Cancer Genomics in WA”. Further information can be found on the project summary page.
- In 2020, funding of up to $9m plus an additional 30% matched funding for up to nine years was awarded to Co-Chief Investigators Professor Peter Leedman (Harry Perkins Institute for Medical Research) and Associate Professor Nina Tirnitz-Parker (Curtin Health Innovation Research Institute) for their grant application “Defeating Primary Liver Cancer”. Further information can be found on the project summary page.
Information and updates on previously funded projects is also available.
News & Events
WA FHRI Fund – CRT Cancer Research Co-funding Partnership announced
The launch of the partnership was announced today by the Hon Stephen Dawson, Minister for Medical Research. This substantial WA Collaborative Cancer Research Grant will provide up to $1 million per annum for a period of five years, with the potential for renewal for an additional four years and has been made possible by a co-funding partnership between the Future Health Research and Innovation (FHRI) Fund and the Cancer Research Trust (CRT) (The Trust).